アナクアが外国特許出願を戦略的アドバンテージに変える 機能・サービス強化を発表
18 avr. 2024 07h00 HE
|
Anaqua
ボストン, April 18, 2024 (GLOBE NEWSWIRE) --...
Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI
18 avr. 2024 07h00 HE
|
Anaqua
BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce...
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
18 avr. 2024 07h00 HE
|
Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
16 avr. 2024 08h00 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
Isuzu Motors Limited Drives Forward with Anaqua as Intellectual Property Management Provider
16 avr. 2024 08h00 HE
|
Anaqua
Anaqua announces global commercial vehicle manufacturer Isuzu Motors as new intellectual property management software client.
PharmAla Announces Private Placement and Concurrent Debt Settlement
10 avr. 2024 16h30 HE
|
PharmAla Biotech
PharmAla Initiates $750,000 Private Placement with concurrent debt settlement, anticipated to close on April 17th 2024
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
10 avr. 2024 07h17 HE
|
Clearmind Medicine Inc.
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and...
Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration
09 avr. 2024 08h08 HE
|
Tome Biosciences
Tome granted US patent for programmable genomic integration.
Anaqua améliore sa plateforme de recherche de brevets AcclaimIP en ajoutant des capacités basées sur l'IA
08 avr. 2024 09h37 HE
|
Anaqua
BOSTON, 08 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, continue d'améliorer sa puissante plateforme de...
Anaqua Enhances AcclaimIP Patent Search with AI-Powered Capabilities
08 avr. 2024 09h37 HE
|
Anaqua
Anaqua revolutionizes patent search with AI-powered AcclaimIP. Explore over 100M patents worldwide with user-friendly interface and cutting-edge AI.